Risk of multiple sclerosis after optic neuritis
Abstract
ObjectiveTo identify factors associated with a high and low risk of developing multiple sclerosis after an initial episode of optic neuritis.MethodsThree hundred eighty-eight patients who experienced acute optic neuritis between July 1, 1988, and June 30, 1991, were followed up prospectively for the development of multiple sclerosis. Consenting patients were reassessed after 10 to 13 years.ResultsThe 10-year risk of multiple sclerosis was 38% (95% confidence interval, 33%-43%). Patients (160) who had 1 or more typical lesions on the baseline magnetic resonance imaging (MRI) scan of the brain had a 56% risk; those with no lesions (191) had a 22% risk (P<.001, log rank test). Among the patients who had no lesions on MRI, male gender and opticdisc swelling were associated with a lower risk of multiple sclerosis, as was the presence of the following atypical features for optic neuritis: no light perception vision; absence ofpain; and ophthalmoscopic findings of severe optic disc edema, peripapillary hemorrhages, or retinal exudates.ConclusionsThe 10-year risk of multiple sclerosis following an initial episode of acute optic neuritis is significantly higher if there is a single brain MRI lesion; higher numbers of lesions do not appreciably increase that risk. However, even when brain lesions are seen on MRI, more than 40% of the patients will not develop clinical multiple sclerosis after 10 years. In the absence of MRI lesions, certain demographic and clinical features seem to predict a very low likelihood of developing multiple sclerosis. This natural history information is a critical input for estimating a patient's 10-year multiple sclerosis risk and for weighing the benefit of initiating prophylactic treatment at the time of optic neuritis or other initial demyelinating events in the central nervous system.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- In silico design of a TLR4-mediating multiepitope chimeric vaccine against amyotrophic lateral sclerosis via advanced immunoinformaticsJournal of Leukocyte Biology · 2022 · 2 shared tags
- Successful Treatment of Posterior Cortical Atrophy: A Case ReportInternational Journal of Translational Medicine · 2026 · 2 shared tags
- Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicineThe EPMA Journal · 2021 · 2 shared tags
- Treatable metabolic and inflammatory abnormalities in Post COVID Syndrome (PCS) define the transcriptomic basis for persistent symptoms: Lessons from CIRSMedical Research Archives · 2021 · 2 shared tags
- Breach and restoration of retinal immune privilege: barrier failure, innate dysregulation, and adaptive autoimmunityFrontiers in Immunology · 2025 · 2 shared tags
- The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptomePigment Cell & Melanoma Research · 2021 · 2 shared tags